• Medical Policies

    Premera offers access to more than 300 medical policies online. Since we’re continually updating these pages, we encourage you to visit often. The policies are in Adobe PDF format. Individual plans use different medical policies. View individual plan medical policies and also View our HMO medical policies.

    Enter one or more keywords. Enter "policy" to see a complete list of policies.

* One or more keywords are required

  Reset search
460 results found for policy
https://www.premera.com/medicalpolicies/5.01.532.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.532 Cutaneous T-Cell Lymphomas (CTCL): Systemic ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.558_2026-07-02.pdf#search=policy
POLICY - 5.01.558 Pharmacologic Treatment of High Cholesterol Effective Date: Jul. 2, 2026* Last Revised: Mar. 10, 2026 Replaces: N/A *Click here to view the current policy. ...
https://www.premera.com/medicalpolicies/7.01.599.pdf#search=policy
MEDICAL POLICY - 7.01.599 Total Ankle Arthroplasty in Adults Effective Date: Jun. 1, 2026 ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/7.01.601.pdf#search=policy
MEDICAL POLICY - 7.01.601 Endovascular Stent Grafts for Abdominal Aortic Aneurysms BCBSA Ref. Policy: 7.01.67 Effective Date: Mar. 4, 2026 Last Revised: Nov. 11, 2025 Replaces: N/...
https://www.premera.com/medicalpolicies/5.01.616.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.616 Pharmacologic Treatment of Gout Effective Date: Jun. ... Medical Necessity criteria within this policy DOES NOT apply to Alaska fully- insured ...
https://www.premera.com/medicalpolicies/5.01.628.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.628 Pharmacologic Treatment of Atopic Dermatitis ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.637.pdf#search=policy
PHARMACY POLICY - 5.01.637 Pharmacologic Treatment of Alopecia Effective Date: Jun. 1, ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.651.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.651 Pharmacologic Treatment of Parkinson's Disease ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/7.01.165.pdf#search=policy
MEDICAL POLICY - 7.01.165 Radiofrequency Coblation Tenotomy for Musculoskeletal Conditions BCBSA Ref. Policy: 7.01.165 Effective Date: Mar. 1, 2026 Last Revised: Feb. 9, 2026 ...
https://www.premera.com/medicalpolicies/10.01.532.pdf#search=policy
MEDICAL POLICY - 10.01.532 ASAM Criteria: Services Reviewed for Medical Necessity ... N/A RELATED MEDICAL POLICIES: None This policy only applies to Washington Individual ...
https://www.premera.com/medicalpolicies/15.01.036.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.036 Diagnosis of Idiopathic Environmental Intolerance Ref. Policy: G2056 Effective Date: Feb. 6, 2026 Last Revised: Feb. 6, 2026 Replaces: N/...
https://www.premera.com/medicalpolicies/2.01.100.pdf#search=policy
MEDICAL POLICY - 2.01.100 Dry Needling of Trigger Points for Myofascial Pain BCBSA Ref. Policy: 2.01.100 Effective Date: Jul. 1, 2025 Last Revised: Jun. 9, 2025 Replaces: N/A ...
https://www.premera.com/medicalpolicies/2.01.106.pdf#search=policy
MEDICAL POLICY - 2.01.106 Percutaneous Electrical Nerve Field Stimulation for Irritable Bowel Syndrome BCBSA Ref. Policy: 2.01.106 Effective Date: Jan. 1, 2026 Last Revised: Dec. ...
https://www.premera.com/medicalpolicies/2.02.26.pdf#search=policy
MEDICAL POLICY - 2.02.26 Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation BCBSA Ref. Policy: 2.02.26 Effective Date: Aug. 1, 2025 ...
https://www.premera.com/medicalpolicies/2.04.152.pdf#search=policy
MEDICAL POLICY - 2.04.152 Maternal Serum Biomarkers for Prediction of Adverse Obstetric Outcomes BCBSA Ref. Policy: 2.04.152 Effective Date: May 1, 2025 Last Revised: Jan. 1, 2026 ...
https://www.premera.com/medicalpolicies/5.01.548.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.548 Pharmacotherapy of Cushing's Disease and Acromegaly ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/7.01.564.pdf#search=policy
MEDICAL POLICY - 7.01.564 Pulsed Radiofrequency for the Treatment of Chronic Pain ... below to be directed to that section. POLICY CRITERIA | CODING | RELATED INFORMATION ...
https://www.premera.com/medicalpolicies/7.01.582.pdf#search=policy
MEDICAL POLICY - 7.01.582 Bioengineered Skin and Soft Tissue Substitutes BCBSA Ref. Policy: 7.01.113 Effective Date: Sep. 1, 2025 Last Revised: Apr. 1, 2026 Replaces: 7.01.113 ...
https://www.premera.com/medicalpolicies/8.01.15.pdf#search=policy
MEDICAL POLICY - 8.01.15 Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma BCBSA Ref. Policy: 8.01.15 Effective Date: Apr. 1, 2026 ...
https://www.premera.com/medicalpolicies/5.01.625.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.625 Gonadotropin Releasing Hormone (GnRH) Analogs ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...